Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Healthcare Triangle, Inc. incurred convertible notes of $2,000,000 maturing 18 months after issuance.
- Instrument
- convertible notes
- Principal
- $2,000,000
- Maturity
- 18 months after issuance
- Event
- incurrence
Exact text from the filing
Under the first tranche of funding, which closed upon signing of the Purchase Agreement on December 28, 2023, the Company issued a Note to the Investor in the principal amount of $2,000,000 which resulted in gross proceeds to the Company of $1,700,000 and Warrants to purchase up to an aggregate of 357,500 Warrant Shares.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.2
Healthcare Triangle, Inc. entered into Securities Purchase Agreement with an institutional investor valued at up to $5,200,000 (effective 2023-12-28).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- an institutional investor
- Value
- up to $5,200,000
- Effective
- 2023-12-28
Exact text from the filing
On December 28, 2023, Healthcare Triangle, Inc., a Delaware corporation (the “ Company ”), entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with an institutional investor (the “ Investor ”), pursuant to which the Company agreed to issue to the Investor Senior Secured 15% Original Issue Discount Convertible Promissory Notes (the “ Notes ”) in the aggregate principal amount of up to $5,200,000 which will result in gross proceeds to the Company in the amount of up to $4,420,000 due to the original issue discount, and warrants
View on SEC.gov